Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
J Pediatr. 2013 Jan;162(1):148-54. doi: 10.1016/j.jpeds.2012.06.057. Epub 2012 Aug 9.
To investigate the association between hepatitis C virus (HCV)-specific cell-mediated immunity (CMI) responses and viral clearance in children born to mothers infected with HCV.
A cross-sectional study of children from a mother-infant cohort in Egypt were enrolled to detect CMI responses to recombinant core and nonstructural HCV antigens (nonstructural segments NS3, NS4a/b, and NS5 of the HCV genome) using an interferon-gamma enzyme-linked immunospot assay. Children born to mothers with chronic HCV were enrolled into 3 groups: transiently viremic (n = 5), aviremic (n = 36), and positive control (n = 6), which consisted of 1 child with chronic HCV from this cohort and another 5 children with chronic HCV from a companion study. Children without HCV born to mothers without HCV (n = 27) served as a negative control group. Wilcoxon rank sum test was used to compare the magnitude of CMI responses between groups.
None of the 6 control children who were positive for HCV responded to any HCV antigen, and 4 (80%) of 5 children with transient viremia responded to at least one HCV antigen, compared with 5 (14%) of 36 and 3 (11%) of 27 children in the aviremic and negative control groups, respectively. Children with transient viremia elicited stronger responses than did negative controls (P = .005), positive controls (P = .011), or children without HCV viremia (P = .012), particularly to nonstructural antigens.
HCV-specific CMI responses were significantly higher in magnitude and frequency among transiently infected children compared with those persistently infected. This suggests CMI responses may be associated with past viral clearance and can identify children at high risk of infection, who can be targeted for health education, screening, and follow-up.
研究丙型肝炎病毒(HCV)特异性细胞介导免疫(CMI)反应与感染 HCV 母亲所生儿童病毒清除之间的关系。
对埃及母婴队列中的儿童进行了一项横断面研究,使用干扰素-γ酶联免疫斑点分析检测对重组核心和非结构 HCV 抗原(HCV 基因组的非结构区 NS3、NS4a/b 和 NS5)的 CMI 反应。将感染 HCV 的母亲所生的儿童分为 3 组:一过性病毒血症(n = 5)、非持续性病毒血症(n = 36)和阳性对照组(n = 6),其中包括本队列中的 1 例慢性 HCV 患儿和来自对照研究的 5 例慢性 HCV 患儿。未感染 HCV 的母亲所生的儿童(n = 27)作为阴性对照组。采用 Wilcoxon 秩和检验比较各组间 CMI 反应的幅度。
6 例 HCV 阳性的对照儿童均未对任何 HCV 抗原产生反应,5 例一过性病毒血症儿童中有 4 例(80%)至少对 1 种 HCV 抗原产生反应,而 36 例非持续性病毒血症儿童中仅有 5 例(14%),27 例阴性对照组儿童中仅有 3 例(11%)。与阴性对照组(P =.005)、阳性对照组(P =.011)或非持续性病毒血症的无 HCV 感染儿童(P =.012)相比,一过性病毒血症儿童的 CMI 反应幅度更大。
与持续性感染儿童相比,一过性感染儿童的 HCV 特异性 CMI 反应在幅度和频率上均显著更高。这表明 CMI 反应可能与过去的病毒清除有关,并可识别出高感染风险的儿童,以便对其进行健康教育、筛查和随访。